WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new fertility treatment options, today announced its plans for 2016. OvaScience will present in a live webcast at the 34th Annual J.P. Morgan Healthcare Conference on Thursday, Jan. 14, 2016, at 9:30 a.m. PST (12:30 p.m. EST) from the Westin St. Francis Hotel in San Francisco.
